Heartbeam Inc (BEAT) Stock Price, Quote & News

Company Profile

HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recordi...

Industry: Health Information Services

Sector: Healthcare

Phone: 408 899 4443

Website: www.heartbeam.com

Address:

2118 Walsh Avenue, Suite 210, Santa Clara, United States

vintage84 Sep. 12 at 12:32 AM

$BEAT have a great weekend! The big move up is coming 👍🍾🚀💰

2 · Reply

nhadar Sep. 11 at 6:30 PM

$BEAT close below 40 today and next week below 30

0 · Reply

nhadar Sep. 11 at 1:58 PM

$BEAT deadbeat lol

1 · Reply

BrightStars Sep. 11 at 12:41 PM

$BEAT that’s all I have to say today.

0 · Reply

Flyhai Sep. 11 at 2:47 AM

$BEAT ironic that this is called BEAT and it's a heart device because this is dead! .39 🤔.

0 · Reply

vintage84 Sep. 11 at 12:07 AM

$BEAT wow under .40 now… I can’t f’in believe it….

1 · Reply

fiat1234 Sep. 10 at 3:34 PM

$BEAT I'd like to know what Humburger has been doing in the last 8 months. Is he alive, dead, talking to anyone. With complete silence there is only one place where share price will end up.

1 · Reply

nhadar Sep. 10 at 2:27 AM

$BEAT 4 $ year Hugo to 0.40 low lol

1 · Reply

peekaboo2 Sep. 9 at 6:12 PM

$BEAT https://www.investing.com/equities/heartbeam-ownership Whenever institutional investors realize retail was right about this stock. We're in for a really fun ride.

1 · Reply

Flyhai Sep. 8 at 7:34 PM

$BEAT What to expect: HeartBeam's ALIGN-ACS pilot study results have been accepted and will be presented at the prestigious Transcatheter Cardiovascular Therapeutics (TCT) 2026 conference in San Diego. Why it moves the stock: This is the company's first major presentation of human trial data for its heart attack detection algorithm in front of the global cardiology community. Strong, peer-reviewed safety and efficacy data frequently triggers immediate volume and price action for micro-cap medical device

1 · Reply

HeartBeam reports Q2 EPS (10c) vs (15c) last year

2026-08-16T14:14:12.000Z - 4 weeks ago

HeartBeam sees Q3 cash flow in line with Q2

Aug 13, 2026, 4:30 PM EDT - 4 weeks ago

HeartBeam Earnings Call Transcript: Q2 2026

Aug 13, 2026, 4:30 PM EDT - 4 weeks ago

HeartBeam Quarterly report: Q2 2026

Aug 13, 2026, 4:30 PM EDT - 4 weeks ago

HeartBeam Slides: Q2 2026

Aug 13, 2026, 4:30 PM EDT - 4 weeks ago

HeartBeam Earnings release: Q2 2026

Aug 13, 2026, 4:01 PM EDT - 4 weeks ago

HeartBeam Reports Second Quarter 2026 Results

Jul 31, 2026, 1:00 PM EDT - 6 weeks ago

HeartBeam Transcript: AGM 2026

Jul 30, 2026, 7:00 AM EDT - 6 weeks ago

HeartBeam to Host Second Quarter 2026 Results Conference Call on Thursday, August 13, 2026 at 4:30 p.m. Eastern Time

2026-07-14T11:55:31.000Z - 2 months ago

HeartBeam initiated with a Buy at Maxim

2026-07-14T11:05:21.000Z - 2 months ago

HeartBeam awarded U.S. patent for ECG device capabilities

2026-06-30T11:05:24.000Z - 2 months ago

HeartBeam completes patient enrollment in ALIGN-ACS pilot study

Jun 30, 2026, 7:00 AM EDT - 2 months ago

HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule

Jun 25, 2026, 8:00 AM EDT - 2 months ago

HeartBeam Proxy statement: Proxy filing

2026-06-24T20:10:41.000Z - 2 months ago

HeartBeam announces strategic shift to ambulatory ECG signal platform

Jun 24, 2026, 4:05 PM EDT - 2 months ago

HeartBeam Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership Transition

Jun 18, 2026, 8:00 AM EDT - 2 months ago

HeartBeam Proxy statement: Proxy filing

Jun 5, 2026, 8:00 AM EDT - 3 months ago

HeartBeam Proxy statement: Proxy filing

Jun 5, 2026, 7:00 AM EDT - 3 months ago

HeartBeam Slides: Investor presentation

2026-06-02T11:05:34.000Z - 3 months ago

HeartBeam announces peer-reviewed article in JACC on HeartBeam ECG

Jun 2, 2026, 7:00 AM EDT - 3 months ago

HeartBeam Announces New Peer-Reviewed Article Demonstrating Potential to Help Identify Heart Attack Risk at Home

2026-05-22T10:10:58.000Z - 3 months ago

HeartBeam price target lowered to $2.50 from $5.50 at H.C. Wainwright

2026-05-15T14:03:56.000Z - 4 months ago

HeartBeam price target lowered to $5 from $8 at Benchmark

May 13, 2026, 4:30 PM EDT - 4 months ago

HeartBeam Earnings Call Transcript: Q1 2026

May 13, 2026, 4:30 PM EDT - 4 months ago

HeartBeam Quarterly report: Q1 2026

May 13, 2026, 4:30 PM EDT - 4 months ago

HeartBeam Slides: Q1 2026

May 13, 2026, 4:30 PM EDT - 4 months ago

HeartBeam Earnings release: Q1 2026

2026-05-13T20:08:51.000Z - 4 months ago

HeartBeam reports Q1 EPS (12c) vs. (18c) last year

May 13, 2026, 4:01 PM EDT - 4 months ago

HeartBeam Reports First Quarter 2026 Results

2026-05-11T15:12:35.000Z - 4 months ago

HeartBeam initiates pilot study of first on-demand 12-lead ECG patch

May 11, 2026, 8:31 AM EDT - 4 months ago

HeartBeam Initiates Pilot Study of First On-Demand 12-Lead ECG Patch to Detect Ischemia Outside the Clinic

2026-05-07T20:27:33.000Z - 4 months ago

HeartBeam announces commercial agreement with Atelier Health

May 7, 2026, 8:31 AM EDT - 4 months ago

HeartBeam Expands Commercial Presence Across Four Key U.S. Markets with Addition of Premier Concierge Practice

Apr 30, 2026, 8:31 AM EDT - 4 months ago

HeartBeam to Host First Quarter 2026 Results Conference Call on Wednesday, May 13, 2026 at 4:30 p.m. Eastern Time

2026-04-20T12:02:38.000Z - 4 months ago

HeartBeam downgraded to Hold from Buy at D. Boral Capital

Apr 16, 2026, 4:05 PM EDT - 5 months ago

HeartBeam Announces Closing of $10 Million Public Offering of Common Stock

Apr 16, 2026, 7:00 AM EDT - 5 months ago

HeartBeam Slides: Investor presentation

2026-04-15T09:55:54.000Z - 5 months ago

HeartBeam 12.5M share Spot Secondary priced at 80c

Apr 14, 2026, 10:00 PM EDT - 5 months ago

HeartBeam Announces Pricing of $10 Million Public Offering of Common Stock

2026-04-14T20:10:16.000Z - 5 months ago

HeartBeam announces common stock offering, no amount given

Apr 14, 2026, 4:05 PM EDT - 5 months ago

HeartBeam Announces Proposed Public Offering of Common Stock

2026-03-31T09:40:38.000Z - 5 months ago

HeartBeam initiated with a Buy at B. Riley

2026-03-31T09:20:14.000Z - 5 months ago

HeartBeam initiated with a Buy at Stifel

2026-03-27T12:37:18.000Z - 5 months ago

HeartBeam initiated with a Buy at D. Boral Capital

Mar 16, 2026, 11:20 AM EDT - 6 months ago

HeartBeam Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Mar 13, 2026, 8:00 AM EDT - 6 months ago

HeartBeam Registration statement: Registration Filing

Mar 12, 2026, 4:30 PM EDT - 6 months ago

HeartBeam Earnings Call Transcript: Q4 2025

Mar 12, 2026, 4:30 PM EDT - 6 months ago

HeartBeam Earnings release: Q4 2025

Mar 12, 2026, 4:30 PM EDT - 6 months ago

HeartBeam Annual report: Q4 2025

Mar 12, 2026, 4:30 PM EDT - 6 months ago

HeartBeam Slides: Q4 2025

2026-03-12T20:05:25.000Z - 6 months ago

HeartBeam reports Q4 EPS (62c) vs (73c) last year

Mar 12, 2026, 4:01 PM EDT - 6 months ago

HeartBeam Reports Fourth Quarter and Full Year 2025 Results

Mar 12, 2026, 7:00 AM EDT - 6 months ago

HeartBeam Slides: Investor presentation

2026-03-10T11:27:46.000Z - 6 months ago

HeartBeam announces AI pact with Icahn School of Medicine at Mount Sinai

Mar 10, 2026, 7:00 AM EDT - 6 months ago

HeartBeam and Mount Sinai Announce Strategic AI Collaboration to Bring Clinical-Grade Heart Monitoring into the Home

Mar 9, 2026, 7:00 AM EDT - 6 months ago

HeartBeam to Attend Investor and Industry Conferences in March, Focused on Providing Updates on Commercial Launch and Unveiling 12-Lead ECG Extended Wear Patch

Mar 5, 2026, 7:00 AM EST - 6 months ago

HeartBeam Announces First Patient Enrollments in Heart Attack Detection Pilot Study

Mar 4, 2026, 4:01 PM EST - 6 months ago

HeartBeam to Host Fourth Quarter Full Year 2025 Results Conference Call on Thursday, March 12, 2026 at 4:30 p.m. Eastern Time

Mar 4, 2026, 7:00 AM EST - 6 months ago

HeartBeam Announces First Commercial Customer as ClearCardio Brings Groundbreaking 12-Lead ECG Technology to High-Growth Preventive Cardiology Market

Feb 9, 2026, 7:00 AM EST - 7 months ago

HeartBeam Registration statement: Registration Filing

Jan 22, 2026, 7:00 AM EST - 7 months ago

HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer

Jan 5, 2026, 7:00 AM EST - 8 months ago

HeartBeam to Attend JP Morgan 2026 Annual Healthcare Conference

Dec 10, 2025, 7:00 AM EST - 9 months ago

HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment

Nov 26, 2025, 4:32 PM EST - 9 months ago

HeartBeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead ECG Synthesis Software Application

Nov 13, 2025, 4:30 PM EST - 10 months ago

HeartBeam Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 10 months ago

HeartBeam Earnings release: Q3 2025

Nov 13, 2025, 4:30 PM EST - 10 months ago

HeartBeam Quarterly report: Q3 2025

Nov 13, 2025, 4:30 PM EST - 10 months ago

HeartBeam Slides: Q3 2025

Nov 13, 2025, 4:01 PM EST - 10 months ago

HeartBeam Reports Third Quarter 2025 Results

Oct 30, 2025, 7:00 AM EDT - 10 months ago

HeartBeam to Host Third Quarter 2025 Results Conference Call on Thursday, November 13, 2025 at 4:30 p.m. Eastern Time

Oct 28, 2025, 7:00 AM EDT - 10 months ago

HeartBeam Teams Up With HeartNexus to Deliver Cardiologist-Level ECG Insights Anytime, Anywhere

Sep 8, 2025, 7:00 AM EDT - 1 year ago

HeartBeam's Deep Learning Algorithms Demonstrate High Rates of Accuracy for Detecting Arrhythmias

Aug 28, 2025, 7:00 AM EDT - 1 year ago

HeartBeam to Participate at Upcoming Industry and Investor Conferences, September 4-10, 2025

Aug 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Earnings Call Transcript: Q2 2025

Aug 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Earnings release: Q2 2025

Aug 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Quarterly report: Q2 2025

Aug 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Slides: Q2 2025

Aug 13, 2025, 4:01 PM EDT - 1 year ago

HeartBeam Reports Second Quarter 2025 Results

Jul 30, 2025, 7:00 AM EDT - 1 year ago

HeartBeam to Host Second Quarter 2025 Results Conference Call on Wednesday, August 13, 2025 at 4:30 p.m. Eastern Time

Jul 22, 2025, 7:00 AM EDT - 1 year ago

HeartBeam Wins Industry Innovation Award for Advancing Remote Cardiac Care With Groundbreaking ECG Technology

Jun 24, 2025, 2:00 PM EDT - 1 year ago

HeartBeam Transcript: IAccess Alpha Virtual Best Ideas Summer Investment Conference 2025

Jun 17, 2025, 7:00 AM EDT - 1 year ago

HeartBeam to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24, 2025

May 29, 2025, 8:00 AM EDT - 1 year ago

HeartBeam Proxy statement: Proxy Filing

May 19, 2025, 8:00 AM EDT - 1 year ago

HeartBeam Proxy statement: Proxy Filing

May 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Earnings Call Transcript: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Earnings release: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Quarterly report: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Slides: Q1 2025

May 13, 2025, 4:01 PM EDT - 1 year ago

HeartBeam Reports First Quarter 2025 Results

May 6, 2025, 7:00 AM EDT - 1 year ago

HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio

May 5, 2025, 7:00 AM EDT - 1 year ago

HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth

May 1, 2025, 8:31 AM EDT - 1 year ago

HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time

Apr 29, 2025, 8:31 AM EDT - 1 year ago

HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology

Apr 24, 2025, 8:31 AM EDT - 1 year ago

HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation

Mar 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Earnings Call Transcript: Q4 2024

Mar 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Annual report: Q4 2024

Mar 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Earnings release: Q4 2024

Mar 13, 2025, 4:30 PM EDT - 1 year ago

HeartBeam Slides: Q4 2024

Mar 13, 2025, 4:01 PM EDT - 1 year ago

HeartBeam Reports Fourth Quarter and Full Year 2024 Results

Mar 6, 2025, 9:01 AM EST - 1 year ago

HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 16-21, 2025

Feb 27, 2025, 8:31 AM EST - 1 year ago

HeartBeam to Host Fourth Quarter Full Year 2024 Results Conference Call on Thursday, March 13, 2025 at 4:30 p.m. Eastern Time

Feb 25, 2025, 4:01 PM EST - 1 year ago

HeartBeam Announces Exercise and Closing of Underwriter's Over-Allotment Option for Public Offering of Common Stock

Feb 13, 2025, 8:31 AM EST - 1 year ago

HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock

Jan 29, 2025, 8:31 AM EST - 1 year ago

HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software

Dec 23, 2024, 8:31 AM EST - 1 year ago

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

Dec 16, 2024, 8:31 AM EST - 1 year ago

HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology

Nov 19, 2024, 8:31 AM EST - 1 year ago

HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference

Nov 7, 2024, 4:30 PM EST - 1 year ago

HeartBeam Earnings Call Transcript: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

HeartBeam Earnings release: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

HeartBeam Quarterly report: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

HeartBeam Slides: Q3 2024

Nov 7, 2024, 4:05 PM EST - 1 year ago

HeartBeam Reports Third Quarter 2024 Results

Oct 31, 2024, 8:31 AM EDT - 1 year ago

HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time

Oct 24, 2024, 8:31 AM EDT - 1 year ago

HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards

Oct 17, 2024, 8:31 AM EDT - 1 year ago

HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization

vintage84 Sep. 12 at 12:32 AM

$BEAT have a great weekend! The big move up is coming 👍🍾🚀💰

2 · Reply

nhadar Sep. 11 at 6:30 PM

$BEAT close below 40 today and next week below 30

0 · Reply

nhadar Sep. 11 at 1:58 PM

$BEAT deadbeat lol

1 · Reply

BrightStars Sep. 11 at 12:41 PM

$BEAT that’s all I have to say today.

0 · Reply

Flyhai Sep. 11 at 2:47 AM

$BEAT ironic that this is called BEAT and it's a heart device because this is dead! .39 🤔.

0 · Reply

vintage84 Sep. 11 at 12:07 AM

$BEAT wow under .40 now… I can’t f’in believe it….

1 · Reply

fiat1234 Sep. 10 at 3:34 PM

$BEAT I'd like to know what Humburger has been doing in the last 8 months. Is he alive, dead, talking to anyone. With complete silence there is only one place where share price will end up.

1 · Reply

nhadar Sep. 10 at 2:27 AM

$BEAT 4 $ year Hugo to 0.40 low lol

1 · Reply

peekaboo2 Sep. 9 at 6:12 PM

$BEAT https://www.investing.com/equities/heartbeam-ownership Whenever institutional investors realize retail was right about this stock. We're in for a really fun ride.

1 · Reply

Flyhai Sep. 8 at 7:34 PM

1 · Reply

Flyhai Sep. 8 at 7:33 PM

$BEAT Late October / Early November: FDA Pre-Submission Window ClosesWhat to expect: Management filed their formal 510(k) pre-submission to the FDA for their at-home heart attack detection technology on August 13, 2026. This officially triggered a 75-day regulatory review window. Why it moves the stock: By late October or early November, the FDA will deliver its formal feedback. If the FDA agrees with HeartBeam's proposed "predicates" (which would shorten and simplify the approval process), it drastically reduces regulatory risk.

0 · Reply

Notespecially99 Sep. 8 at 5:58 PM

$BEAT Growth Strategy – Following clearance, HeartBeam plans a limited commercial launch in early 2026 while advancing heart attack detection, an extended-wear 12-lead patch, and AI-powered longitudinal ECG analytics based on its 3D ECG data platform.

0 · Reply

Notespecially99 Sep. 8 at 5:07 PM

$BEAT October 24, 2024, medical technology company HeartBeam, Inc. (NASDAQ: BEAT) announced that it was named a "Rising Star" in the 'Home Health Diagnostic' category at the 6th Annual Digital Health Hub Foundation Awards

1 · Reply

Notespecially99 Sep. 6 at 8:24 PM

$BEAT Two potential catalysts at the end of October: 1.)The FDA is expected to respond on October 27, 2026, which is exactly 75 calendar days after HeartBeam submitted its pre-submission. 2.)Heartbeam is scheduled to present full clinical data from its VALIDATE-ECG study at the upcoming TCT 2026 (Transcatheter Cardiovascular Therapeutics) Conference in San Diego. The conference takes place from October 31 to November 3, 2026. Potentially (3) Bid price to $1.00 by December 28, 2026.

1 · Reply

Bearbull_Baggins Sep. 6 at 5:26 PM

$BEAT I feel like its just a matter of time...but how low will she go beforehand? The compliance deadline is right around the time this thing has a bullish reversal every year.

1 · Reply

Notespecially99 Sep. 6 at 1:38 PM

$BEAT Great product idea. Would be a great asset to hospitals especially post cardiac procedures.

0 · Reply

Notespecially99 Sep. 6 at 1:35 PM

$BEAT There’s Hope! HeartBeam, Inc. (NASDAQ: BEAT) entered into a $25 million ATM equity offering sales agreement with Titan Partners Securities LLC. Other past or concurrent transactions managed by the group include firms like Quantum Computing Inc., Altimmune, and Solidion Technology. ( Cite source Google AI)

0 · Reply

BrightStars Sep. 6 at 1:23 PM

$BEAT these guys need to take lessons from GoPro ! Merge with someone !!!!!!!

2 · Reply

Notespecially99 Sep. 6 at 1:08 PM

$BEAT From Google AI: Nasdaq deficiency letter on June 30, 2026, declaring the stock noncompliant because its closing bid price had fallen below the US$1.00 minimum requirement for 30 consecutive days. The company has been granted a standard 180-day compliance window—lasting until December 28, 2026—to bring its share price back above $1.00 for at least 10 consecutive business days

0 · Reply

Notespecially99 Sep. 6 at 1:04 PM

$BEAT From Google AI; The TCT 2026 conference (Transcatheter Cardiovascular Therapeutics) will take place from October 31 to November 3, 2026. The annual symposium is being held at the San Diego Convention Center in San Diego, California. HeartBeam is scheduled to present the full results of its ALIGN-ACS pilot study during this four-day window

0 · Reply

Notespecially99 Sep. 6 at 12:58 PM

$BEAT Sounds like a great product! It will put alot of telemetry manufacturers, cable and electrode companies out of business if the price is right. Would be smart to let a major manufacturer buy and market the product.

0 · Reply

JOLI2025 Sep. 5 at 11:43 AM

$BEAT

0 · Reply

Market Cap	22.90M
Revenue (ttm)	0.00
Net Income (ttm)	-21.02M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	275,800
Avg Vol	682,272
Day's Range	N/A - N/A
Shares Out	56.35M
Stochastic %K	19%
Beta	-0.80
Analysts	Sell
Price Target	$3.17